(2R)-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxy-2-phenylacetic acid → ((4S)-2-thioxohexahydropyrimidin-4-yl)methyl(2R)-2-((1R)-3,3-difluorocyclopentyl)-2-hydroxy-2-phenylethanoate
Reaktionsgleichung
[F:1][C:2]1([F:18])[CH2:6][CH2:5][C@@H:4]([C@@:7]([OH:17])([C:11]2[CH:16]=[CH:15][CH:14]=[CH:13][CH:12]=2)[C:8]([OH:10])=[O:9])[CH2:3]1.O[CH2:20][C@@H:21]1[CH2:26][CH2:25][NH:24][C:23](=[S:27])[NH:22]1>>[F:1][C:2]1([F:18])[CH2:6][CH2:5][C@@H:4]([C@@:7]([OH:17])([C:11]2[CH:12]=[CH:13][CH:14]=[CH:15][CH:16]=2)[C:8]([O:10][CH2:20][C@@H:21]2[CH2:26][CH2:25][NH:24][C:23](=[S:27])[NH:22]2)=[O:9])[CH2:3]1Komponenten
3
Versuchsvorschrift
Using (2R)-2-((1R)-3,3-difluorocyclopentyl)-2-hydroxy-2-phenylacetic acid and (4S)-4-(hydroxymethyl)tetrahydropyrimidine-2(1H)-thione, the title compound was prepared by a method similar to Step 2 of Referential Example 12.
Quellen und Nachweise
- ORD-Eintrag
- ord-5888c27d571a46b3b6c9f69781d6646f
- Quelldatensatz
- uspto-grants-2009_03
- Patentnummer
- US07504432B2
Notizen zur Reaktion
Wird geladen…